Rapid growth continues at Liberty Health Sciences, increasing accessibility to heavily populated areas of Fort Lauderdale and Hollywood
TORONTO, Feb. 14, 2019 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of high quality cannabis, announced today that on February 19th the Company will open its first dispensary in Broward County, in the city of Dania Beach. The Dania Beach location will serve a population of approximately 1.9 million people, and the new dispensary provides customers in the Fort Lauderdale and Hollywood area access to premium marijuana products in a relaxed environment that reinforces consistent quality, customer care and one-on-one education outreach.
Located at 1103 S. Federal Highway, Dania Beach, FL., the new dispensary is open Monday through Friday, 10 a.m. to 7 p.m., Saturday, 10 a.m. to 5 p.m., and Sunday 12 p.m. to 5 p.m. Strategically situated in a high traffic area on the historical Federal Highway (US1), which was formally established in 1926 by the Florida Department of Transportation, tens of thousands of vehicles utilize the corridor daily in order to commute to and from work, or simply for leisure and vacationing.
"We are aggressively accelerating our store count to fulfill our largest obligation, of which is accessibility of pharma grade products," said George Scorsis, CEO of Liberty. "We are excited to open our Dania Beach location, which will prove to be a very popular destination as we continue to concentrate on making our premium products and services available to more customers across Florida. Dania Beach will continue to showcase our esthetically appealing and patient accommodating store layouts accompanied by innovative and engaging displays. The new dispensary also features a waiting room, along with private consultation rooms, to safely and comfortably serve our customers."
The new store opening follows yesterday's opening of the North Miami location and the Miami dispensary grand opening on Bird Road on December 11, 2018. After Dania Beach, Liberty currently expects to open an additional two dispensaries, for a total of 12 locations in Florida by the end of February 2019, subject to the receipt of Florida Department of Health approvals.
Liberty is currently operating 20,000 square feet of cultivation space at the Liberty 360 Innovation Campus property, as well as 40,000 square feet at the original Alachua property, to support the growing demand for its product. The next phase at Liberty 360 Innovation Campus, planned to be completed by March of this year, is expected to add an additional 80,000 square feet of cultivation space, with a further 80,000 square feet is anticipated to be added this summer. Liberty currently employs just under 200 people across its operations and dispensaries. With the anticipated completion of Liberty 360 Innovation Campus, the Company expects to employ a diverse workforce of up to 300 people, including patient liaisons, scientists, engineers and cultivation specialists.
About Liberty Health Sciences Inc.
Liberty is the cannabis provider committed to providing a trusted, high quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale. Liberty's measured approach to expansion opportunities is focused on maximizing returns to shareholders, while keeping consumers' well-being at the forefront of what we do. For more information, please visit: www.libertyhealthsciences.com.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains certain forward-looking statements within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "believe", "plan", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, expectations related to the Company's production capabilities, expectations concerning the receipt of all necessary approvals from the Florida Department of Health, expectations concerning the opening of new dispensaries and the expansion of its greenhouse space, and the Company's future expansion and growth strategies. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the medical marijuana industry in the United States generally, income tax and regulatory matters; the ability of Liberty to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
SOURCE Liberty Health Sciences Inc.
For further information: Media Contacts: Dwain Schenck, 203-223-5230, email@example.com; Stephanie Kubacki, Vice-President, Marketing, 415-830-7337, firstname.lastname@example.org